XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,739,000 | -63.0% | 1,118 | -38.5% | 0.00% | – |
| Q2 2021 | $7,399,000 | -72.7% | 1,818 | -69.7% | 0.00% | – |
| Q1 2021 | $27,060,000 | -39.9% | 6,000 | -34.4% | 0.00% | – |
| Q4 2020 | $45,018,000 | -31.5% | 9,150 | -17.5% | 0.00% | – |
| Q3 2020 | $65,734,000 | +750.9% | 11,085 | +281.7% | 0.00% | – |
| Q2 2020 | $7,725,000 | -57.1% | 2,904 | -68.6% | 0.00% | – |
| Q1 2020 | $18,006,000 | -16.9% | 9,234 | +200.6% | 0.00% | – |
| Q4 2019 | $21,658,000 | -38.0% | 3,072 | -13.6% | 0.00% | – |
| Q3 2019 | $34,946,000 | +32.1% | 3,555 | +53.7% | 0.00% | – |
| Q2 2019 | $26,461,000 | -38.5% | 2,313 | -46.0% | 0.00% | – |
| Q1 2019 | $43,041,000 | – | 4,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Investment Research & Advisory Group, Inc. | 803 | $2,000 | 0.00% |